Taysha Gene Therapies, Inc. announced that Kathleen Reape provided notice to the board of directors of the Company of her decision to resign from the Board, effective November 1, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.96 USD | -0.34% | -4.82% | +67.23% |
May. 14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
May. 14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.23% | 555M | |
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- TSHA Stock
- News Taysha Gene Therapies, Inc.
- Taysha Gene Therapies, Inc. Announces Resignation of Kathleen Reape as Director, Effective November 1, 2023